Yura Ahn, Sang Min Lee, Jooae Choe, Sehoon Choi, Kyung-Hyun Do, Joon Beom Seo
{"title":"Prevalence and Risk Factors for Pathologic N2 Disease in Resected Lung Cancers Assessed as N0 or N1 Disease on Preoperative Imaging.","authors":"Yura Ahn, Sang Min Lee, Jooae Choe, Sehoon Choi, Kyung-Hyun Do, Joon Beom Seo","doi":"10.2214/AJR.24.32486","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> In certain patients with lung cancer, guidelines recommend endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) as the primary method to evaluate for metastatic mediastinal lymph nodes, defining pN2 disease. EBUS-TBNA has associated costs and complications and possibly limited availability. <b>Objectives:</b> To investigate the prevalence and risk factors for pN2 disease in patients undergoing resection of lung cancer assessed as having radiologic N0 or N1 disease. <b>Methods:</b> This retrospective study included 3581 patients (mean age, 63.8±9.4 years; 1917 male, 1664 female) with lung cancer who underwent chest CT and FDG PET/CT showing radiologic N0 or N1 disease before resection between January 2015 and December 2021. Tumor characteristics were assessed on chest CT. Patients were assessed for presence of guideline-based indications for EBUS-TBNA as evaluation for imaging-occult N2 disease. Pathologic N categories were determined from surgical specimens. Preoperative risk factors for pN2 disease were identified using logistic regression analyses. <b>Results:</b> A total of 1936 patients had radiologic rN0 disease without EBUS-TBNA indication, 1348 had radiologic N0 disease with EBUS-TBNA indication, and 297 had radiologic N1 disease. These groups had prevalence of pN2a disease of 4.1%, 6.5%, and 18.5%, respectively, and of pN2b disease of 1.2%, 2.4%, and 14.8%, respectively. In multivariable analyses, independent risk factors for pN2 disease in patients with radiologic N0 disease without EBUS-TBNA indication were female sex (OR=1.66), larger size of the tumor's solid portion (OR=1.05 [95% CI, 1.01-1.10]), pure-solid nodule (OR=5.53 [95% CI, 3.15-9.72]), and spiculation (OR=2.66 [95% CI, 1.72-4.11]); with radiologic N0 disease with EBUS-TBNA indication were younger age (OR=0.97 [95% CI, 0.96-0.99] per year), pure-solid nodule (OR=1.75 [95% CI, 1.10-2.80]), and lobulation (OR=1.96 [95% CI, 1.23-3.11]); and with radiologic N1 disease were younger age (OR=0.973 [95% CI, 0.948-0.999] per year), female sex (OR=2.91 [95% CI, 1.66-5.11]) and spiculation (OR=2.81 [95% CI, 1.66-4.76]). <b>Conclusion:</b> pN2b disease was uncommon in patients with radiologic N0 disease, regardless of indications for EBUS-TBNA, and increased in prevalence in patients with radiologic N1 disease. <b>Clinical Impact:</b> The identified risk factors can inform patient selection for EBUS-TBNA, to aid detection of occult pN2 disease.</p>","PeriodicalId":55529,"journal":{"name":"American Journal of Roentgenology","volume":" ","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Roentgenology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2214/AJR.24.32486","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Background: In certain patients with lung cancer, guidelines recommend endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) as the primary method to evaluate for metastatic mediastinal lymph nodes, defining pN2 disease. EBUS-TBNA has associated costs and complications and possibly limited availability. Objectives: To investigate the prevalence and risk factors for pN2 disease in patients undergoing resection of lung cancer assessed as having radiologic N0 or N1 disease. Methods: This retrospective study included 3581 patients (mean age, 63.8±9.4 years; 1917 male, 1664 female) with lung cancer who underwent chest CT and FDG PET/CT showing radiologic N0 or N1 disease before resection between January 2015 and December 2021. Tumor characteristics were assessed on chest CT. Patients were assessed for presence of guideline-based indications for EBUS-TBNA as evaluation for imaging-occult N2 disease. Pathologic N categories were determined from surgical specimens. Preoperative risk factors for pN2 disease were identified using logistic regression analyses. Results: A total of 1936 patients had radiologic rN0 disease without EBUS-TBNA indication, 1348 had radiologic N0 disease with EBUS-TBNA indication, and 297 had radiologic N1 disease. These groups had prevalence of pN2a disease of 4.1%, 6.5%, and 18.5%, respectively, and of pN2b disease of 1.2%, 2.4%, and 14.8%, respectively. In multivariable analyses, independent risk factors for pN2 disease in patients with radiologic N0 disease without EBUS-TBNA indication were female sex (OR=1.66), larger size of the tumor's solid portion (OR=1.05 [95% CI, 1.01-1.10]), pure-solid nodule (OR=5.53 [95% CI, 3.15-9.72]), and spiculation (OR=2.66 [95% CI, 1.72-4.11]); with radiologic N0 disease with EBUS-TBNA indication were younger age (OR=0.97 [95% CI, 0.96-0.99] per year), pure-solid nodule (OR=1.75 [95% CI, 1.10-2.80]), and lobulation (OR=1.96 [95% CI, 1.23-3.11]); and with radiologic N1 disease were younger age (OR=0.973 [95% CI, 0.948-0.999] per year), female sex (OR=2.91 [95% CI, 1.66-5.11]) and spiculation (OR=2.81 [95% CI, 1.66-4.76]). Conclusion: pN2b disease was uncommon in patients with radiologic N0 disease, regardless of indications for EBUS-TBNA, and increased in prevalence in patients with radiologic N1 disease. Clinical Impact: The identified risk factors can inform patient selection for EBUS-TBNA, to aid detection of occult pN2 disease.
期刊介绍:
Founded in 1907, the monthly American Journal of Roentgenology (AJR) is the world’s longest continuously published general radiology journal. AJR is recognized as among the specialty’s leading peer-reviewed journals and has a worldwide circulation of close to 25,000. The journal publishes clinically-oriented articles across all radiology subspecialties, seeking relevance to radiologists’ daily practice. The journal publishes hundreds of articles annually with a diverse range of formats, including original research, reviews, clinical perspectives, editorials, and other short reports. The journal engages its audience through a spectrum of social media and digital communication activities.